Apyx Medical (APYX) Other financing activities (2012 - 2026)

Apyx Medical's (APYX) quarterly Other financing activities came in at $428000.0 in Q4 2025, up 613.33% on a QoQ basis from $60000.0 in Q2 2025.

Apyx Medical (APYX) Other financing activities (2012 - 2026) Analysis & Trends

Apyx Medical (APYX) has 11 years of Other financing activities data on file, last reported at $428000.0 in Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $428000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $488000.0 (changed N/A YoY) and the FY2025 annual result came in at $488000.0, changed N/A from the prior year.
Other financing activities grew to $428000.0 in Q4 2025, from $60000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $586000.0 in Q1 2023 to a low of -$439000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn
10	Apyx Medical	136.81 Mn	109.19 Mn	8.87 Mn

Download Data